Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
26.17
+0.45 (1.75%)
Aug 14, 2025, 2:24 PM - Market open
Nektar Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -122.27 | -118.96 | -276.06 | -368.2 | -523.84 | -444.44 | Upgrade
|
| Depreciation & Amortization | 1.97 | 4.39 | 7.82 | 13.03 | 14.15 | 14.18 | Upgrade
|
| Loss (Gain) From Sale of Assets | -40.39 | -40.39 | 1.3 | -3.33 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 8.33 | 111.83 | 70.71 | 16.7 | - | Upgrade
|
| Stock-Based Compensation | 17.58 | 21.61 | 33.39 | 57.32 | 94.67 | 94.26 | Upgrade
|
| Other Operating Activities | -34.47 | -44.45 | -50.94 | -74.04 | 8.63 | 5.96 | Upgrade
|
| Change in Accounts Receivable | -3.05 | -3.05 | 4.78 | 16.51 | 12.4 | 1.91 | Upgrade
|
| Change in Inventory | 1.43 | 0.5 | 0.7 | -3.4 | -0.51 | -2.63 | Upgrade
|
| Change in Accounts Payable | 8.82 | 2.67 | -2.88 | 3.1 | -11.69 | 2.38 | Upgrade
|
| Change in Unearned Revenue | - | - | - | - | - | -5.52 | Upgrade
|
| Change in Other Net Operating Assets | -21.36 | -6.36 | -22.53 | -15.72 | -23.17 | 20.6 | Upgrade
|
| Operating Cash Flow | -184.91 | -175.71 | -192.61 | -304.01 | -412.66 | -313.29 | Upgrade
|
| Capital Expenditures | -1.16 | -1.47 | -0.87 | -5.68 | -14.99 | -7.26 | Upgrade
|
| Sale of Property, Plant & Equipment | 65.39 | 65.39 | 1.25 | 13.2 | - | - | Upgrade
|
| Investment in Securities | 136.11 | 78.65 | 139.18 | 358.32 | 217.77 | 503.47 | Upgrade
|
| Other Investing Activities | -0.7 | - | - | - | - | - | Upgrade
|
| Investing Cash Flow | 199.63 | 142.57 | 139.56 | 365.84 | 202.78 | 496.21 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | - | -250 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | - | - | -250 | Upgrade
|
| Issuance of Common Stock | 0.31 | 0.12 | 0.03 | 0.76 | 33.24 | 23.4 | Upgrade
|
| Repurchase of Common Stock | - | -3 | - | - | - | - | Upgrade
|
| Other Financing Activities | - | 45 | - | 0.75 | 3 | 146.25 | Upgrade
|
| Financing Cash Flow | 0.31 | 42.12 | 0.03 | 1.51 | 36.24 | -80.35 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.01 | -0 | 0.06 | -0.33 | -0.09 | 0.02 | Upgrade
|
| Net Cash Flow | 15.05 | 8.98 | -52.95 | 63.01 | -173.74 | 102.59 | Upgrade
|
| Free Cash Flow | -186.07 | -177.18 | -193.47 | -309.68 | -427.65 | -320.55 | Upgrade
|
| Free Cash Flow Margin | -248.32% | -180.01% | -214.68% | -336.41% | -419.65% | -209.62% | Upgrade
|
| Free Cash Flow Per Share | -13.27 | -12.92 | -15.27 | -24.82 | -35.00 | -26.92 | Upgrade
|
| Cash Interest Paid | - | - | - | - | - | 9.74 | Upgrade
|
| Cash Income Tax Paid | 0.08 | 0.08 | 2.66 | 0.27 | 0.33 | 0.54 | Upgrade
|
| Levered Free Cash Flow | -58.48 | -43.69 | -63.63 | -101.13 | -234.18 | -125.51 | Upgrade
|
| Unlevered Free Cash Flow | -41.9 | -26.12 | -47.8 | -83.06 | -204.61 | -102.31 | Upgrade
|
| Change in Working Capital | -14.17 | -6.24 | -19.94 | 0.49 | -22.97 | 16.75 | Upgrade
|
Updated May 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.